ES2191778T3 - Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b. - Google Patents

Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b.

Info

Publication number
ES2191778T3
ES2191778T3 ES96940766T ES96940766T ES2191778T3 ES 2191778 T3 ES2191778 T3 ES 2191778T3 ES 96940766 T ES96940766 T ES 96940766T ES 96940766 T ES96940766 T ES 96940766T ES 2191778 T3 ES2191778 T3 ES 2191778T3
Authority
ES
Spain
Prior art keywords
descladinous
desoxi
erythromycins
derivatives
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96940766T
Other languages
English (en)
Inventor
Yat Sun Or
Daniel T Chu
Richard L Elliott
Daisy Pireh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/729,269 external-priority patent/US5747466A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2191778T3 publication Critical patent/ES2191778T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN COMPUESTO SELECCIONADO DE ENTRE LOS GRUPOS (I), (II) Y (III), EN DONDE A, B, V, W, X Y R 8 SE DEFINEN ESPECIFICAMENTE; SUS COMPOSICIONES FARMACEUTICAS; UN PROCEDIMIENTO DE TRATAR O PREVENIR INFECCIONES BACTERIANAS ADMINISTRANDO SUS COMPOSICIONES FARMACEUTICAS TERAPEUTICAMENTE EFECTIVAS; Y UN PROCEDIMIENTO PARA SU PREPARACION.
ES96940766T 1995-11-08 1996-11-06 Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b. Expired - Lifetime ES2191778T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US634295P 1995-11-08 1995-11-08
US08/729,269 US5747466A (en) 1995-11-08 1996-10-10 3-deoxy-3-descladinose derivatives of erythromycins A and B

Publications (1)

Publication Number Publication Date
ES2191778T3 true ES2191778T3 (es) 2003-09-16

Family

ID=26675509

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96940766T Expired - Lifetime ES2191778T3 (es) 1995-11-08 1996-11-06 Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b.

Country Status (13)

Country Link
EP (1) EP0874863B1 (es)
JP (1) JP2000501077A (es)
KR (1) KR19990067333A (es)
AT (1) ATE231878T1 (es)
AU (1) AU714176B2 (es)
CA (1) CA2235681A1 (es)
DE (1) DE69626040T2 (es)
DK (1) DK0874863T3 (es)
ES (1) ES2191778T3 (es)
IL (1) IL123386A0 (es)
MX (1) MX9803694A (es)
PT (1) PT874863E (es)
WO (1) WO1997017357A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757518B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives

Also Published As

Publication number Publication date
EP0874863A1 (en) 1998-11-04
DE69626040T2 (de) 2004-01-22
EP0874863B1 (en) 2003-01-29
PT874863E (pt) 2003-06-30
AU1074497A (en) 1997-05-29
JP2000501077A (ja) 2000-02-02
CA2235681A1 (en) 1997-05-15
KR19990067333A (ko) 1999-08-16
WO1997017357A1 (en) 1997-05-15
MX9803694A (es) 1998-09-30
ATE231878T1 (de) 2003-02-15
DK0874863T3 (da) 2003-05-26
IL123386A0 (en) 1998-09-24
DE69626040D1 (de) 2003-03-06
AU714176B2 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
EA199901016A1 (ru) 9-оксим-производные эритромицина
ES2196331T3 (es) Derivados macrociclicos de cadena de 13 elementos de las eritromicinas a y b.
FI951468A (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
PT876388E (pt) Derivados de eritromicina triciclica
CA2253338A1 (en) 6-o-substituted erythromycins and method for making them
AU544790B2 (en) Epimeric azahomoerythromycin a derivatives
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
ATE255589T1 (de) Kristallin form i von clarithromycin
CA2349338A1 (en) Novel macrolide antibiotics
AU5254696A (en) Reduced toxicity compositions and methods for treating hiv infections
BR9708930A (pt) Composto derivado de 3-descladinose-2,3-anidro-eritromicina ou um seu sal ou éster farmaceuticamente aceitável processo para a preparação do composto composição farmacêutica e processo de tratamento de infecções bacterianas
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
ES2159733T3 (es) Compuestos de dialquiltiacumicina.
MD1788F2 (en) Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
ES2191778T3 (es) Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b.
TR200201145T2 (tr) Hidromisin türevleri
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno